Apixaban Krka 2.5 mg film-coat. tabl. Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apixaban krka 2.5 mg film-coat. tabl.

krka d.d. novo mesto d.d. - apixaban 2,5 mg - film-coated tablet - 2,5 mg - apixaban 2.5 mg - apixaban

Apixaban Krka 5 mg film-coat. tabl. Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apixaban krka 5 mg film-coat. tabl.

krka d.d. novo mesto d.d. - apixaban 5 mg - film-coated tablet - 5 mg - apixaban 5 mg - apixaban

Apixaban Sandoz 2.5 mg film-coat. tabl. Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apixaban sandoz 2.5 mg film-coat. tabl.

sandoz sa-nv - apixaban 2,5 mg - film-coated tablet - 2,5 mg - apixaban 2.5 mg - apixaban

Apixaban 2.5 mg film-coated tablets Malta - inglise - Malta Medicines Authority

apixaban 2.5 mg film-coated tablets

renata pharmaceuticals (ireland) limited 12 crowe street, dundalk, co. louth, a91 nn29, , ireland - film-coated tablet - apixaban 2.5 mg - antithrombotic agents

Apixaban 5 mg film-coated tablets Malta - inglise - Malta Medicines Authority

apixaban 5 mg film-coated tablets

renata pharmaceuticals (ireland) limited 12 crowe street, dundalk, co. louth, a91 nn29, , ireland - film-coated tablet - apixaban 5 mg - antithrombotic agents

ELIQUIS 2.5 MG Iisrael - inglise - Ministry of Health

eliquis 2.5 mg

pfizer pharmaceuticals israel ltd - apixaban - film coated tablets - apixaban 2.5 mg - apixaban - apixaban - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery.prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

ELIQUIS 5 MG Iisrael - inglise - Ministry of Health

eliquis 5 mg

pfizer pharmaceuticals israel ltd - apixaban - film coated tablets - apixaban 5 mg - apixaban - apixaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adults.

ELIQUIS apixaban 2.5 mg film-coated tablet blister pack Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

eliquis apixaban 2.5 mg film-coated tablet blister pack

bristol-myers squibb australia pty ltd - apixaban, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose; sodium lauryl sulfate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - eliquis is indicated for the prevention of venous thromboembolic events (vte) in adult patients who have undergone elective total hip or total knee replacement surgery.,eliquis is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,eliquis is indicated for the treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adult patients.,eliquis is indicated for the prevention of recurrent dvt and pe in adult patients.

ELIQUIS apixaban 5 mg film-coated tablet blister pack Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

eliquis apixaban 5 mg film-coated tablet blister pack

bristol-myers squibb australia pty ltd - apixaban, quantity: 5 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; microcrystalline cellulose; lactose; purified water; magnesium stearate; croscarmellose sodium; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide red - eliquis is indicated for the prevention of venous thromboembolic events (vte) in adult patients who have undergone elective total hip or total knee replacement surgery.,eliquis is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,eliquis is indicated for the treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adult patients.,eliquis is indicated for the prevention of recurrent dvt and pe in adult patients.